Company intelligence / Profile preview
Phoenix Life Sciences
Sydney, New South Wales, Australiaphoenixlife.co ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Phoenix Life Sciences delivers plant-based pharmaceutical products and healthcare management services with a primary focus on diabetes management and expanding indications in pain, cancer, autoimmunity, anxiety, and related diseases, primarily deployed at the clinic and community care level in developing and emerging markets. The company's flagship program, PHOENIX METABOLIC, targets type 2 diabetes management and complications, and programs are active and expanding in the Western Pacific with global ambitions.[2]
- Therapeutic areas
- ImmunologyEndocrinologyNeurologyPsychiatryOncology
- Modalities
- Plant based pharmaceuticalSmall molecule
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Beyond the preview
Go deeper on Phoenix Life Sciences.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Phoenix Life Sciences.